Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-24-024047

Director bought 900,000 shares at $18.00 ($16,200,000)

  • Director acquired 2,113,975 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Pande Vijay Satyanand · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-27 Conversion : show line 1 in the form +855,972 855,972 I
2024-09-27 Conversion : show line 2 in the form +413,100 1,269,072 I
2024-09-27 Conversion : show line 3 in the form +189,609 189,609 I
2024-09-27 Conversion : show line 4 in the form +655,294 655,294 I
2024-09-27 Purchase : show line 5 in the form +900,000 $18.00 $16,200,000 900,000 I
Open-market purchases · 900,000 sh · avg $18.00 · $16,200,000

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-09-27 Conversion : show line 6 in the form Series A-1 Preferred Stock −3,819,863 0 I
2024-09-27 Conversion : show line 7 in the form Series B Preferred Stock −1,843,502 0 I
2024-09-27 Conversion : show line 8 in the form Series C Preferred Stock −846,152 0 I
2024-09-27 Conversion : show line 9 in the form Series D Preferred Stock −2,924,318 0 I
Loading xslF345X05/form4-09272024_080956.xml…